206 related articles for article (PubMed ID: 18288924)
1. Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?
Nawa A; Tanino T; Luo C; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Nishiyama Y; Kikkawa F
Anticancer Agents Med Chem; 2008 Feb; 8(2):232-9. PubMed ID: 18288924
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-2'-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity.
Tanino T; Nawa A; Kondo E; Kikkawa F; Daikoku T; Tsurumi T; Luo C; Nishiyama Y; Takayanagi Y; Nishimori K; Ichida S; Wada T; Miki Y; Iwaki M
Pharm Res; 2007 Mar; 24(3):555-65. PubMed ID: 17245652
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
[TBL] [Abstract][Full Text] [Related]
4. Novel gene-directed enzyme prodrug therapies against prostate cancer.
Russell PJ; Khatri A
Expert Opin Investig Drugs; 2006 Aug; 15(8):947-61. PubMed ID: 16859396
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic stability of 2'-ethylcarbonate-linked paclitaxel in serum and conversion to paclitaxel by rabbit liver carboxylesterase for use in prodrug/enzyme therapy.
Tanino T; Nawa A; Miki Y; Iwaki M
Biopharm Drug Dispos; 2008 Jul; 29(5):259-69. PubMed ID: 18496885
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer.
Chen L; Waxman DJ
Curr Pharm Des; 2002; 8(15):1405-16. PubMed ID: 12052216
[TBL] [Abstract][Full Text] [Related]
7. Viral vectors for gene-directed enzyme prodrug therapy.
Schepelmann S; Springer CJ
Curr Gene Ther; 2006 Dec; 6(6):647-70. PubMed ID: 17168697
[TBL] [Abstract][Full Text] [Related]
8. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
Roy P; Waxman DJ
Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
[TBL] [Abstract][Full Text] [Related]
9. Prodrug cancer gene therapy.
Altaner C
Cancer Lett; 2008 Nov; 270(2):191-201. PubMed ID: 18502571
[TBL] [Abstract][Full Text] [Related]
10. From bench to bedside for gene-directed enzyme prodrug therapy of cancer.
Dachs GU; Tupper J; Tozer GM
Anticancer Drugs; 2005 Apr; 16(4):349-59. PubMed ID: 15746571
[TBL] [Abstract][Full Text] [Related]
11. Gene-directed enzyme prodrug therapy.
Zhang J; Kale V; Chen M
AAPS J; 2015 Jan; 17(1):102-10. PubMed ID: 25338741
[TBL] [Abstract][Full Text] [Related]
12. Prodrugs in genetic chemoradiotherapy.
Patterson AV; Saunders MP; Greco O
Curr Pharm Des; 2003; 9(26):2131-54. PubMed ID: 14529410
[TBL] [Abstract][Full Text] [Related]
13. Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: a tangible union against chemoresistant cancer.
Singh PP; Joshi S; Russell PJ; Nair S; Khatri A
BMC Cancer; 2011 Aug; 11():368. PubMed ID: 21861932
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.
Niculescu-Duvaz I; Cooper RG; Stribbling SM; Heyes JA; Metcalfe JA; Springer CJ
Curr Opin Mol Ther; 1999 Aug; 1(4):480-6. PubMed ID: 11713763
[TBL] [Abstract][Full Text] [Related]
15. Targeted, gene-directed enzyme prodrug therapies to tackle diversity and aggression of late stage prostate cancer.
Khatri A; Russell PJ
Discov Med; 2007 Feb; 7(37):39-45. PubMed ID: 17343804
[TBL] [Abstract][Full Text] [Related]
16. Advances in imaging gene-directed enzyme prodrug therapy.
Bhaumik S
Curr Pharm Biotechnol; 2011 Apr; 12(4):497-507. PubMed ID: 21342105
[TBL] [Abstract][Full Text] [Related]
17. Introduction to the background, principles, and state of the art in suicide gene therapy.
Niculescu-Duvaz I; Springer CJ
Mol Biotechnol; 2005 May; 30(1):71-88. PubMed ID: 15805578
[TBL] [Abstract][Full Text] [Related]
18. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT.
Tietze LF; Schmuck K
Curr Pharm Des; 2011; 17(32):3527-47. PubMed ID: 22074425
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy enhances the efficacy of gene-directed enzyme prodrug therapy.
Christie C; Pomeroy A; Nair R; Berg K; Hirschberg H
Photodiagnosis Photodyn Ther; 2017 Jun; 18():140-148. PubMed ID: 28257943
[TBL] [Abstract][Full Text] [Related]
20. Organic anion transporting polypeptide 2-mediated uptake of paclitaxel and 2'-ethylcarbonate-linked paclitaxel in freshly isolated rat hepatocytes.
Tanino T; Nawa A; Nakao M; Noda M; Fujiwara S; Iwaki M
J Pharm Pharmacol; 2009 Aug; 61(8):1029-35. PubMed ID: 19703346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]